Search filters

List of works by Angelo Delmonte

A first in human phase I study of the proteasome inhibitor CEP-18770 in patients with advanced solid tumours and multiple myeloma

scientific article published on 08 October 2012

AVE8062: a new combretastatin derivative vascular disrupting agent.

scientific article published on October 2009

Bordetella bronchiseptica pneumonia in a patient with lung cancer; a case report of a rare infection.

scientific article published on 25 September 2017

Clinical impact of sequential treatment with ALK-TKIs in patients with advanced ALK-positive non-small cell lung cancer: Results of a multicenter analysis.

scientific article published on 14 September 2015

Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells.

scientific article published on 10 July 2017

Complications of percutaneous radiofrequency thermal ablation of primary and secondary lesions of the liver

scientific article published on 01 July 2007

EGFR tyrosine kinase inhibitors beyond focal progression obtain a prolonged disease control in patients with advanced adenocarcinoma of the lung

scientific article

Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report.

scientific article

Features and prognostic factors of large node-negative non-small-cell lung cancers shifted to stage II.

scientific article published in July 2012

Gene mutation analysis in EGFR wild type NSCLC responsive to erlotinib: are there features to guide patient selection?

scientific article

Hepatic intra-arterial cetuximab in combination with 5-fluorouracil and cisplatin as salvage treatment for sorafenib-refractory hepatocellular carcinoma

scientific article published on 01 November 2011

Impact of TP53 Mutations on Outcome in EGFR-Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors.

scientific article published on 25 October 2016

Integrative population pharmacokinetic and pharmacodynamic dose finding approach of the new camptothecin compound namitecan (ST1968).

scientific article

Molecular features and clinical outcome of lung malignancies in very young people

scientific article published on January 2015

Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study.

scientific article published on 16 June 2017

Molecule-targeted agents in endometrial cancer.

scientific article published on September 2008

Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy.

scientific article published on December 2015

Optimizing clinical care in patients with advanced soft tissue sarcoma: a phase II study of a new schedule of high-dose continuous infusion ifosfamide and doxorubicin combination.

scientific article

Percutaneous ultrasound-guided radiofrequency thermal ablation of malignant osteolyses

scientific article

Phase I safety, pharmacokinetic and pharmacodynamic evaluation of the vascular disrupting agent ombrabulin (AVE8062) in patients with advanced solid tumors

scientific article published on 5 July 2013

Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors

scientific article (publication date: November 2014)

Phase ib of sorafenib in combination with everolimus in patients with advanced solid tumors, selected on the basis of molecular targets.

scientific article published on 27 March 2014

Phase-I dose finding and pharmacokinetic study of the novel hydrophilic camptothecin ST-1968 (namitecan) in patients with solid tumors

scientific article

Radiofrequency ablation combined with percutaneous ethanol injection in the treatment of hepatocellular carcinoma and portal vein neoplastic thrombosis

scientific article

Safety of Systemic Chemotherapy in a Patient With Mitochondrial Myopathy and Non–Small-Cell Lung Cancer

scientific article published on 20 August 2012

Safety of concomitant administration of seasonal and/or H1N1 flu vaccination in patients receiving erlotinib for advanced non-small cell lung cancer

scientific article published in May 2010

Scrotal involvement in Madelung disease: clinical, ultrasound and MR findings

scientific article published in July 2006

Simultaneous determination of cyclophosphamide, ifosfamide, doxorubicin, epirubicin and daunorubicin in human urine using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry: bioanalytical method validation.

scientific article published in September 2008

Spontaneous rupture of non-parasitic hepatic cyst.

scientific article

Targeting ALK in patients with advanced non small cell lung cancer: biology, diagnostic and therapeutic options

scientific article published on 26 September 2013

Targeting Chromatin-Mediated Transcriptional Control of Gene Expression in Non-Small Cell Lung Cancer Therapy: Preclinical Rationale and Clinical Results

scientific article published on 07 September 2015

The choice of whether to participate in a phase I clinical trial: increasing the awareness of patients with cancer. An exploratory study

scientific article published on 10 October 2013

Vaccines in non-small cell lung cancer: rationale, combination strategies and update on clinical trials.

scientific article published on 25 February 2012